FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for benztropine mesylate from Hikma Pharmaceuticals USA Inc., indicating an approved change to an existing ANDA for this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystonia
• Extrapyramidal Symptoms
• Parkinson Disease

Drugs mentioned

• Benztropine Mesylate (benztropine mesylate)

Snippet

SUPPL AP for BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)